| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.088 | 0.02 |